4-(2-((6-((Cyanomethyl)carbamoyl)-2-(3,4-dichloro-5-methyl-1H-pyrrole-2-carboxamido)benzo[d]thiazol-4-yl)oxy)ethyl)morpholin-4-ium chloride

ID: ALA4876030

PubChem CID: 164627023

Max Phase: Preclinical

Molecular Formula: C22H23Cl3N6O4S

Molecular Weight: 537.43

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1[nH]c(C(=O)Nc2nc3c(OCCN4CCOCC4)cc(C(=O)NCC#N)cc3s2)c(Cl)c1Cl.Cl

Standard InChI:  InChI=1S/C22H22Cl2N6O4S.ClH/c1-12-16(23)17(24)19(27-12)21(32)29-22-28-18-14(34-9-6-30-4-7-33-8-5-30)10-13(11-15(18)35-22)20(31)26-3-2-25;/h10-11,27H,3-9H2,1H3,(H,26,31)(H,28,29,32);1H

Standard InChI Key:  RBPRMPXFSQQPIS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 36 38  0  0  0  0  0  0  0  0999 V2000
    8.8648  -20.8792    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    7.3119  -19.3768    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0283  -18.9636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0254  -18.1330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3101  -17.7239    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5972  -18.9640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5984  -18.1351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8104  -17.8777    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.3221  -18.5476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8084  -19.2189    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5002  -18.5465    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0887  -17.8315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2637  -17.8304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5021  -17.1177    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7799  -17.1584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9949  -17.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9938  -18.2373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7781  -18.4931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3253  -18.7242    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    8.7383  -17.7178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4544  -18.1277    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7352  -16.8928    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0304  -19.2802    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.3282  -16.9265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3075  -20.2036    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0198  -20.6200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0154  -21.4448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7276  -21.8612    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7180  -22.6829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4261  -23.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1452  -22.6939    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.1515  -21.8680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4388  -21.4473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1672  -17.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8832  -18.1222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6001  -18.5298    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  6  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  7  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  6  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 13  2  0
 17 19  1  0
  4 20  1  0
 20 21  1  0
 20 22  2  0
 18 23  1  0
 16 24  1  0
  2 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 21 34  1  0
 34 35  1  0
 35 36  3  0
M  END

Associated Targets(non-human)

gyrB DNA gyrase (2092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
gyrB DNA gyrase (1168 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 537.43Molecular Weight (Monoisotopic): 536.0800AlogP: 3.46#Rotatable Bonds: 8
Polar Surface Area: 132.37Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.96CX Basic pKa: 6.51CX LogP: 2.55CX LogD: 2.50
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -2.14

References

1. Durcik M, Nyerges Á, Skok Ž, Skledar DG, Trontelj J, Zidar N, Ilaš J, Zega A, Cruz CD, Tammela P, Welin M, Kimbung YR, Focht D, Benek O, Révész T, Draskovits G, Szili PÉ, Daruka L, Pál C, Kikelj D, Mašič LP, Tomašič T..  (2021)  New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens.,  213  [PMID:33524686] [10.1016/j.ejmech.2021.113200]

Source